GlassScriptPhysician profile
Alexander Kulik
NPI 1558524967
$1,995.87
in general payments reported to CMS, 2019-2025
11 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $73.52 · 2022: $147 · 2023: $61.52 · 2024: $22.70 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987 · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.12 |
| Travel and Lodging | $363.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $934.48 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $258.80 | 2024-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Abbott Laboratories | $182.53 | 2019 | |
| Heron Therapeutics, INC. | $124.46 | 2025 | Zynrelef, Aponvie |
| Janssen Pharmaceuticals, INC | $120.98 | 2019 | |
| Medical Device Business Services, INC. | $120.55 | 2019 | |
| Ethicon INC. | $92.14 | 2022 | |
| Medtronic Vascular, INC. | $73.52 | 2020 | |
| Getinge USA Sales, LLC | $55.23 | 2022 | |
| Lsi Solutions INC | $33.18 | 2023 | Cor Knot |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Kulik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.